BC Cancer Agency
Vancouver, British Columbia
Mechanisms of Lenalidomide resistance
Myelodysplastic syndrome (MDS) is a type of blood cancer that has very few types of treatment available. The aim of this project is to understand why patients with a specific type of MDS become resistant to the only treatment they have available. We hope that understanding this mechanism will also provide clues to overcome resistance to the therapy.